Pravin Dugel - Executive Chairman, President and CEO, Director at OCULAR THERAPEUTIX, INC

Issuer-level insider activity

Role
Executive Chairman, President and CEO, Director
Issuer ticker
OCUL on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for Pravin Dugel in OCULAR THERAPEUTIX, INC

Buys

Open market
Shares
Avg price
Total value

Sells

Open market
Shares
-207,273
Avg price
$9.34
Total value
-$1,936,777

Net

Past year
Shares
-207,273
Share %
-100%
Total value
-$1,936,777

Reported holdings for Pravin Dugel in OCULAR THERAPEUTIX, INC

Form 4 holding Executive Chairman, President and CEO, Director

OCULAR THERAPEUTIX, INC

Security class
Common Stock
Shares / value
744,903
Estimated value
$7,314,947
Report date
25 Aug 2026
Price
$9.82
Ownership
By Pravin Dugel 2024 Irrevocable Trust
Form 4 holding Executive Chairman, President and CEO, Director

OCULAR THERAPEUTIX, INC

Security class
Performance Stock Option (Right to Buy)
Shares / value
2,750,000
Estimated value
Report date
11 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Pravin Dugel in OCULAR THERAPEUTIX, INC

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .